{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:16:34Z","timestamp":1784740594322,"version":"3.55.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"JSPS KAKENHI","award":["23K08317"],"award-info":[{"award-number":["23K08317"]}]},{"name":"JSPS KAKENHI","award":["23K08317"],"award-info":[{"award-number":["23K08317"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Overlapping morphological features of mesothelial cells have been rendered it difficult to distinguish between reactive and malignant conditions. The development of methods based on detecting genomic abnormalities using immunohistochemistry and fluorescence in\u00a0situ\u00a0hybridization have contributed markedly to solving this problem. It is important to identify bland mesothelioma cells on cytological screening, perform efficient genomic-based testing, and diagnose mesothelioma, because the first clinical manifestation of pleural mesothelioma is pleural effusion, which is the first sample available for pathological diagnosis. However, certain diagnostic aspects remain challenging even for experts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      This report describes a case of a 72-year-old man with a history of asbestos exposure who presented with pleural effusion as the first symptom and was eventually diagnosed as mesothelioma. Mesothelioma was suspected owing to prominent cell-in-cell engulfment in mesothelial cells on the first cytological sample, and the diagnosis of mesothelioma in situ was confirmed by histology. Unexpectedly, sarcomatoid morphology of mesothelioma was found in the second pathology samples 9\u00a0months after the first pathological examination. Both the mesothelioma in situ and invasive lesion showed immunohistochemical loss of methylthioadenosine phosphorylase (MTAP) and homozygous deletion of cyclin dependent kinase inhibitor 2A (\n                      <jats:italic>CDKN2A<\/jats:italic>\n                      ) on fluorescence in situ hybridization\n                      <jats:italic>.<\/jats:italic>\n                      The patient received medication therapy but died of disease progression 12\u00a0months after the diagnosis of the sarcomatoid morphology of mesothelioma.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Our case suggests that cell-in-cell engulfment can be conspicuous in early-stage mesothelioma with inconspicuous nuclear atypia and few multinucleated cells. In addition, the presence of MTAP loss and\n                      <jats:italic>CDKN2A<\/jats:italic>\n                      homozygous deletion are suspected to be involved in early formation to invasive lesions and\/or sarcomatoid morphology. We believe that it is important to consider genetic abnormalities when deciding on individual patient management. Furthermore, cases of mesothelioma, even those of an in situ lesion, with MTAP loss and\/or\n                      <jats:italic>CDKN2A<\/jats:italic>\n                      deletion should be carefully followed up or subjected to early treatment.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13000-023-01416-7","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T06:04:22Z","timestamp":1701151462000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Sarcomatoid mesothelioma diagnosed in a patient with mesothelioma in situ: a case report on morphologic differences after 9-month interval with details analysis of cytology in early-stage mesothelioma"],"prefix":"10.1186","volume":"18","author":[{"given":"Miho","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0423-3568","authenticated-orcid":false,"given":"Naoe","family":"Jimbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuko","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoo","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9103-6719","authenticated-orcid":false,"given":"Kunimitsu","family":"Kawahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suguru","family":"Mitsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6541-1754","authenticated-orcid":false,"given":"Yugo","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimasa","family":"Maniwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,28]]},"reference":[{"key":"1416_CR1","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/cncy.22398","volume":"129","author":"A Eccher","year":"2021","unstructured":"Eccher A, Girolami I, Lucenteforte E, Troncone G, Scarpa A, Pantanowitz L. Diagnostic mesothelioma biomarkers in effusion cytology. Cancer Cytopathol. 2021;129:506\u201316. https:\/\/doi.org\/10.1002\/cncy.22398.","journal-title":"Cancer Cytopathol"},{"key":"1416_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.5795\/jjscc.42.10","volume":"42","author":"S Hamakawa","year":"2003","unstructured":"Hamakawa S, Mori K, Kashiwazaki Y, Tanabe M, Kondo Y, Sakamaki K, et al. Molded mesothelial cells with hump-like cytoplasmic process in effusion cytology of malignant mesothelioma. J Jpn Soc Clin Cytol. 2003;42:10\u20136. https:\/\/doi.org\/10.5795\/jjscc.42.10.","journal-title":"J Jpn Soc Clin Cytol"},{"key":"1416_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000509886","volume":"65","author":"S Haefliger","year":"2021","unstructured":"Haefliger S, Savice Prince S, Rebetez J, Borer H, Bubendorf L. Putative malignant pleural mesothelioma in situ (MPMIS) with sequential acquisition of genomic alterations on fluorescence in situ hybridization (FISH) examination. Acta Cytol. 2021;65:99\u2013104. https:\/\/doi.org\/10.1159\/000509886.","journal-title":"Acta Cytol"},{"key":"1416_CR4","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00428-019-02674-x","volume":"476","author":"K Minami","year":"2020","unstructured":"Minami K, Jimbo N, Tanaka Y, Hokka D, Miyamoto Y, Itoh T, et al. Malignant mesothelioma in situ diagnosed by methylthioadenosine phosphorylase loss and homozygous deletion of CDKN2A: a case report. Virchows Arch. 2020;476:469\u201373. https:\/\/doi.org\/10.1007\/s00428-019-02674-x.","journal-title":"Virchows Arch"},{"key":"1416_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00428-022-03281-z","volume":"481","author":"M Nishikubo","year":"2022","unstructured":"Nishikubo M, Jimbo N, Tanaka Y, Tachihara M, Itoh T, Maniwa Y. Sarcomatoid mesothelioma originating from mesothelioma in situ: are methylthioadenosine phosphorylase loss and CDKN2A homozygous deletion poor prognostic factors for preinvasive mesothelioma? Virchows Arch. 2022;481:307\u201312. https:\/\/doi.org\/10.1007\/s00428-022-03281-z.","journal-title":"Virchows Arch"},{"key":"1416_CR6","doi-asserted-by":"publisher","unstructured":"Hjerpe A, Ascoli V, Bedrossian CWM, Boon ME, Creaney J, Davidson B, et al.\u00a0Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology.\u00a0Acta Cytol. 2015;59:2\u201316. https:\/\/doi.org\/10.1159\/000377697","DOI":"10.1159\/000377697"},{"key":"1416_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/cncy.21269","volume":"121","author":"S Matsumoto","year":"2013","unstructured":"Matsumoto S, Nabeshima K, Kamei T, Hiroshima K, Kawahara K, Hata S, et al. Morphology of 9p21 homozygous deletion-positive pleural mesothelioma cells analyzed using fluorescence in situ hybridization and virtual microscope system in effusion cytology. Cancer Cytopathol. 2013;121:415\u201322. https:\/\/doi.org\/10.1002\/cncy.21269.","journal-title":"Cancer Cytopathol"},{"key":"1416_CR8","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/pin.12862","volume":"69","author":"S Matsumoto","year":"2019","unstructured":"Matsumoto S, Hamasaki M, Kinoshita Y, Kamei T, Kawahara K, Nabeshima K. Morphological difference between pleural mesothelioma cells in effusion smears with either BAP1 loss or 9p21 homozygous deletion and reactive mesothelial cells without the gene alterations. Pathol Int. 2019;69:637\u201345. https:\/\/doi.org\/10.1111\/pin.12862.","journal-title":"Pathol Int"},{"key":"1416_CR9","first-page":"151","volume":"9","author":"D Whitaker","year":"1992","unstructured":"Whitaker D, Henderson DW, Shilkin KB. The concept of mesothelioma in situ: implications for diagnosis and histogenesis. Semin Diagn Pathol. 1992;9:151\u201361.","journal-title":"Semin Diagn Pathol"},{"key":"1416_CR10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41379-019-0347-0","volume":"33","author":"A Churg","year":"2020","unstructured":"Churg A, Galateau-Salle F, Roden AC, Attanoos R, von der Thusen JH, Tsao MS, et al. Malignant mesothelioma in situ: morphologic features and clinical outcome. Mod Pathol. 2020;33:297\u2013302. https:\/\/doi.org\/10.1038\/s41379-019-0347-0.","journal-title":"Mod Pathol"},{"key":"1416_CR11","doi-asserted-by":"publisher","unstructured":"Churg A, Naso JR. The separation of benign and malignant mesothelial proliferations: new markers and how to use\u00a0them. Am. J. Surg. Pathol. 2020;44:e100\u201312). https:\/\/doi.org\/10.1097\/PAS.0000000000001565","DOI":"10.1097\/PAS.0000000000001565"},{"key":"1416_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/cncy.21928","volume":"126","author":"Y Kinoshita","year":"2018","unstructured":"Kinoshita Y, Hida T, Hamasaki M, Matsumoto S, Sato A, Tsujimura T, et al. A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma. Cancer Cytopathol. 2018;126:54\u201363. https:\/\/doi.org\/10.1002\/cncy.21928.","journal-title":"Cancer Cytopathol"},{"key":"1416_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.lungcan.2016.07.011","volume":"99","author":"M Hamasaki","year":"2016","unstructured":"Hamasaki M, Matsumoto S, Abe S, Hamatake D, Kamei T, Hiroshima K, et al. Low homozygous\/high heterozygous deletion status by p16 FISH correlates with a better prognostic group than high homozygous deletion status in malignant pleural mesothelioma. Lung Cancer. 2016;99:155\u201361. https:\/\/doi.org\/10.1016\/j.lungcan.2016.07.011.","journal-title":"Lung Cancer"},{"key":"1416_CR14","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.pathol.2020.12.005","volume":"53","author":"S Klebe","year":"2021","unstructured":"Klebe S, Nakatani Y, Dobra K, Butnor KJ, Roden AC, Nicholson AG, et al. The concept of mesothelioma in situ, with consideration of its potential impact on cytology diagnosis. Pathology. 2021;53:446\u201353. https:\/\/doi.org\/10.1016\/j.pathol.2020.12.005.","journal-title":"Pathology"},{"key":"1416_CR15","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.cell.2007.10.040","volume":"131","author":"M Overholtzer","year":"2007","unstructured":"Overholtzer M, Mailleux AA, Mouneimne G, Normand G, Schnitt SJ, King RW, et al. A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion. Cell. 2007;131:966\u201379. https:\/\/doi.org\/10.1016\/j.cell.2007.10.040.","journal-title":"Cell"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-023-01416-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-023-01416-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-023-01416-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T06:10:03Z","timestamp":1701151803000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-023-01416-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,28]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1416"],"URL":"https:\/\/doi.org\/10.1186\/s13000-023-01416-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1991950\/v1","asserted-by":"object"}]},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,28]]},"assertion":[{"value":"24 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"126"}}